W
WLC

Latest

Longevity Medicine News

Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.

All clinics diagnostics longevity clinics longevity-clinic-comparison regulation best-longevity-clinics evidence-based healthspan industry-news longevity longevity-treatments aging research biohacking clinical-trials clinique-la-prairie longevity-clinics longevity-diagnostics longevity-industry longevity-science NAD-therapy peptide-therapy progevita aging aging-research biomarkers BPC-157 business cleveland-clinic clinic-comparison clinical trials evidence FDA-regulation fountain-life hospital-longevity-programs innovation lanserhof longevity treatments longevity-medicine longevity-medicine-europe NMN NR plasmapheresis preventive-health research sha-wellness-clinic stem cells affordable-longevity-europe aging frailty AI diagnostics AI-drug-discovery allogeneic stem cells Alzheimer-disease AMAALA anti-aging-science anti-aging-treatments ARPA-H Austin-Texas best-longevity-clinics-europe best-longevity-clinics-spain best-longevity-clinics-usa biograph biological age reversal biological-age blood-filtering-therapy buchinger-wilhelmi cellular-senescence centenarians chenot-palace Cleveland Clinic compounding-pharmacies cruise-ship-wellness drug-combo editorial EMA epigenetic-clock epigenetics european-longevity-clinics european-wellness evidence-based-medicine executive health executive-health franchises genomics geroscience Human Longevity human-longevity-inc industry-trends inflammation investment ipamorelin joe-rogan longevity medicine longevity-clinic-europe longevity-clinic-guide longevity-clinics-expansion longevity-expansion longevity-medical-tourism longevity-ranking longevity-testing longevity-tourism luxury-longevity luxury-wellness-europe marketing mayo-clinic media medical tourism men health MSC therapy mTOR inhibitors NAD+ neurodegenerative-disease Niagen oxytocin palazzo-fiuggi peptides performance pharmaceutical-industry prevention privacy programs proteomics protocols rapamycin regenerative regenerative medicine regenerative-medicine regulatory-policy risk Saudi-Arabia senolytics sports medicine startups stem cell therapy TGF-beta therapeutic plasma exchange therapeutic-fasting TPE treatment-comparison treatments United States US-longevity-clinics UT Health San Antonio VO2-max Ways2Well wellness
ScienceDaily: Scientists say NAD+ could slow aging and fight Alzheimer's and Parkinson's Peer-reviewed

NAD+ and Alzheimer's: What the Latest Research Actually Shows (2026)

A March 2026 Nature Aging review by 25+ scientists from the University of Oslo and international collaborators consolidates the evidence for NAD+ in neurodegenerative disease. Here's what the science says — and what it doesn't.

NAD-therapy Alzheimer-disease neurodegenerative-disease
Lifespan.io: Cellular Senescence and Senotherapeutics: The Expert Roundup Peer-reviewed

Senolytics in 2026: Clinical Trials, Failures, and What Longevity Clinics Are Actually Offering

Senolytics promised to extend healthspan by clearing senescent cells. But recent clinical trial setbacks have cooled the hype. Here's the real state of the field in 2026: which companies are advancing, what failed, what clinics offer, and what the science actually supports.

senolytics cellular-senescence anti-aging-treatments
Nature Metabolism / PubMed Peer-reviewed

NAD+ in Humans: The Review That Cuts Through the Hype (Nature Metabolism, 2025)

A systematic review in Nature Metabolism concludes that clinical evidence for NAD+ supplementation in humans remains scarce and results are heterogeneous. More research needed.

NAD+ evidence clinical-trials